Category Archives: The dismal science

Good Riddance, Alan Greenspan

Cataloguing some of the less-well recognized ways that Alan Greenspan did tremendous harm to the financial system and citizens at large.

Read more...

Michael Hudson: Debts That Cannot Be Paid Won’t Be

R. C. J. Cranstoun spoke with Michael Hudson on debt, rentierism, and the geopolitical rift around sanctions, energy, and the dollar system

Read more...

Coffee Break: The Furies are Coming for US

Today’s Coffee Break on a holiday weekend in the US  is the simple recommendation that you go straight to this long essay in Front Porch Republic by W. Aaron Vandiver of Carbondale, Colorado: Trump and the Furies of Empire –– Trump, in his crude way, is forcing us to confront the false stories we have […]

Read more...

Michael Hudson Warns: Imminent Economic Catastrophe – War, Oil Crisis & Bond Market Panic

Michael Hudson explains how the financier-friendly medicine of higher interest rates will only make the impending economic crisis worse.

Read more...

Coffee Break: Scientists and the Growth Economy, Sternly Worded Letters, Scientist Runs Afoul of RFKJr, Timothy Snyder with the Editor of Science, and Wither Food

Dear gentle readers: Apologies for a somewhat ragged Coffee Break today.  Traveling in Scotland and time has been taken up with details (all good) along with a few unexpected disconnects (as in stuff happens). Part the First: Scientists to the Rescue?  Economic growth is not the answer to any of our problems in this finite […]

Read more...

Economic Management in War: Professor Michael Hudson in Discussion with Ian Proud

An informative and wide-ranging conversation of how economic policies can neglect, support, or impede the prosecution of war

Read more...

Coffee Break: Alzheimer’s Disease Still a Mystery and Books Worth Reading

Part the First: Anti-amyloid Antibodies and Alzheimer’s Disease (AD).  A Cochrane review of monoclonal antibodies targeting amyloid plaques in AD has found that these drugs have little to no effect on cognitive function of AD patients.  Cochrane reviews are, to use one of the favorite tropes of the current administration, considered the “gold standard” of […]

Read more...